Megan Munsie PhD is a highly experienced interdisciplinary researcher who combines her scientific expertise with a deep understanding of the ethical, legal and societal implications of stem cell science and its clinical translation. Her work focuses on understanding community attitudes and expectation in regenerative medicine and other emerging technologies, and the development of policy and professional standards to enable responsible translation of stem cell and related research. Findings from her research have influenced policy reforms at a national and international level, and informed the design and delivery of educational resources for patients, healthcare professionals and the general public for over a decade.
She has been involved in stem cell research since the mid 1990s, has led public education and policy activities for a series of major Australian Government funded programs in stem cell science, and currently heads the preparedness program for the international Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW). She is also a Professor of Emerging Technology (Stem Cells) at the Melbourne Medical School and co-lead of the University of Melbourne Collaborative for Better Health and Regulation.
Megan is Vice President of the Australasian Society for Stem Cell Research and serves on advisory committees to peak national and international bodies including the International Society for Stem Cell Research and International Society for Cell and Gene Therapy. She has extensive experience in biotechnology and has also worked for ten years as a clinical embryologist in Australian IVF clinics. She completed her Masters and PhD at Monash University and her science degree at the Queensland University of Technology.